Evidence map›Paper›PMID 34983638›Full record

ArticleMolecular autism2022

Delineating the autistic phenotype in children with neurofibromatosis type 1.

Anita K Chisholm, Kristina M Haebich, Natalie A Pride, Karin S Walsh, Francesca Lami, Alex Ure, Tiba Maloof, Amanda Brignell, Melissa Rouel, Yael Granader and 8 more

Open access · goldAbstract read
In one paragraph

Article in Molecular autism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 5 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 5 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Unveiling the complexity of neurofibromatosis type 1: Innovations in genetic understanding and clinical management. A narrative review.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Neuropsychiatric phenotypes in children with Noonan syndrome.Developmental medicine and child neurology · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Anita K ChisholmMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Kristina M HaebichMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Natalie A PrideKids Neuroscience Centre, The Children's Hospital at Westmead, 178A Hawkesbury Road, Westmead, NSW, 2145, Australia.
Karin S WalshCenter for Neuroscience and Behavioral Medicine, Children's National Hospital, Michigan Avenue NW, Washington, DC, 20310, USA.
Francesca LamiMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Alex UreMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Tiba MaloofDepartment of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3010, Australia.
Amanda BrignellMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Melissa RouelKids Neuroscience Centre, The Children's Hospital at Westmead, 178A Hawkesbury Road, Westmead, NSW, 2145, Australia.
Yael GranaderCenter for Neuroscience and Behavioral Medicine, Children's National Hospital, Michigan Avenue NW, Washington, DC, 20310, USA.
Alice MaierMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Belinda BartonKids Neuroscience Centre, The Children's Hospital at Westmead, 178A Hawkesbury Road, Westmead, NSW, 2145, Australia.
Hayley DarkeMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Gabriel DabscheckMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Vicki A AndersonMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Katrina WilliamsMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Kathryn N NorthMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Jonathan M PayneMurdoch Children's Research Institute, 50 Flemington Road, Parkville, VIC, 3052, Australia. jonathan.payne@mcri.edu.au.ORCID 0000-0001-9565-3845
Royal Children's Hospital · AUThe University of Melbourne · AUChildren's Hospital at Westmead · AUMurdoch Children's Research Institute · AUMonash Children’s Hospital · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExisting research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF1 remains unclear. To address this gap, we performed detailed characterisation of autistic behaviours in children with NF1 and investigated their association with other common NF1 child characteristics.

methodsParticipants were drawn from a larger cross-sectional study examining autism in children with NF1. The population analysed in this study scored above threshold on the Social Responsiveness Scale-Second Edition (T-score ≥ 60; 51% larger cohort) and completed the Autism Diagnostic Interview-Revised (ADI-R) and/or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2). All participants underwent evaluation of their intellectual function, and behavioural data were collected via parent questionnaires.

resultsThe study cohort comprised 68 children (3-15 years). Sixty-three per cent met the ADOS-2 'autism spectrum' cut-off, and 34% exceeded the more stringent threshold for 'autistic disorder' on the ADI-R. Social communication symptoms were common and wide-ranging, while restricted and repetitive behaviours (RRBs) were most commonly characterised by 'insistence on sameness' (IS) behaviours such as circumscribed interests and difficulties with minor changes. Autistic behaviours were weakly correlated with hyperactive/impulsive attention deficit hyperactivity disorder (ADHD) symptoms but not with inattentive ADHD or other behavioural characteristics. Language and verbal IQ were weakly related to social communication behaviours but not to RRBs. LIMITATIONS: Lack of genetic validation of NF1, no clinical diagnosis of autism, and a retrospective assessment of autistic behaviours in early childhood.

conclusionsFindings provide strong support for elevated autistic behaviours in children with NF1. While these behaviours were relatively independent of other NF1 comorbidities, the importance of taking broader child characteristics into consideration when interpreting data from autism-specific measures in this population is highlighted. Social communication deficits appear similar to those observed in idiopathic autism and are coupled with a unique RRB profile comprising prominent IS behaviours. This autistic phenotype and its relationship to common NF1 comorbidities such as anxiety and executive dysfunction will be important to examine in future research. Current findings have important implications for the early identification of autism in NF1 and clinical management.

Indexed as

Autistic DisorderNeurofibromatosis 1Child, PreschoolCross-Sectional StudiesHumansPhenotypeRetrospective StudiesAutismAutism Diagnostic Interview-Revised (ADI-R)Autism Diagnostic Observation Schedule-Second Edition (ADOS-2)Autistic behavioursNeurofibromatosis type 1

Identifiers

PMID34983638
PMCPMC8729013
OpenAlexW4206511001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.